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Immunoproliferative small intestinal disease (originally called Mediterranean
lymphoma and subsequently alpha chain disease) is a slowly progressive low
grade primary small intestinal B-cell lymphoma characterized by the synthesis
ofa truncated alpha heavy chain without light chain by the neoplastic cells. The
histological features of IPSID and low grade primary gastric B-cell lymphoma
are closely similar and recapitulate the those ofPeyer's patches. This observa-
tion has led to the mucosa associated lymphoid tissue (MALT) lymphoma con-
cept which encompasses a group ofextranodal lymphomas including IPSID and
primary gastric lymphoma. Unlike nodal low-grade B-cell lymphomas, IPSID
and low grade gastric lymphoma remain localized to their sites oforigin for pro-
longed periods. One possible explanation for this is that the growth of these
lymphomas is influenced by a local antigen. This is supported by reports ofclin-
ical remissions induced in IPSID following sterilization of the small intestine
using broad spectrum antibiotics. Similar findings have been reported in low
grade gastric lymphoma following eradication of Helicobacter pylori which is
almost invariably present in the patients' stomachs. Laboratory experiments
have shown that the growth oflymphomatous B-cells is stimulated viaH. pylori
specific T-cells. Further work is required to identify the antigen(s) operative in
IPSID and, possibly, other low grade B-cell lymphomas.
IMMUNOPROLIFERATIVE SMALL INTESTINAL DISEASE
A high prevalence ofsmall intestinal lymphoma in the middle east was first noted by
Azar in 1962 [1]. This finding was subsequently confirmed by Frand and Ramot [2] and,
later, Ramot [3] followed by Eidelman [4] identified a specific subset ofthese cases which
were characterized by severe malabsorption. Reports of the association of this newly
described disease, at first called "Mediterranean lymphoma" with an abnormal
immunoglobulin alpha heavy chain in the serum [5] led to the term "alpha chain disease".
As more cases were reported from an increasing number oflocalities, including the Cape
area of South Africa, where the first cases were reported in 1973, it became clear that the
term Mediterranean lymphoma was inappropriate and also that alpha chain paraprotein
was not always present in the serum [6]. At a specially convened World Health
Organization conference the term Immunoproliferative Small Intestinal Disease (IPSID)b
was adopted as a more appropriate term [7].
Initially, IPSID was considered to represent a spectrum ofdisorders with similar clin-
ical and histological features but the definition soon narrowed to indicate a disorder char-
acterized by profound malabsorption and lymphoplasmacytic infiltration of the small
intestinal mucosa together with the presence ofalpha heavy chain in the serum, duodenal
juice or, in the nonsecretory form, confined to the cytoplasm of the infiltrating plasma
cells [8]. The perception was, and to a certain extent still is, that the lymphoplasmacytic
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infiltrate is initially benign (stage A) but, with time, eventually becomes lymphomatous
(stages B and C) [9]. Various studies purported to show that this transformation from
benign hyperplasia to frank lymphoma was heralded both by increasing "dysplasia" and
depth of invasion of plasma cells. Curiously, this view prevailed despite the fact that
regional lymph node infiltration was well recognized in the early stages of IPSID [9].
Isaacson and co-workers challenged these concepts. With the help of immunohisto-
chemistry [10, 11], they and subsequently others [12] showed that, even in stageA, IPSID
is characterized by two cell populations. Apart from mature IgA-synthesizing plasma
cells, which occupy most ofthe laminapropria, there are also variable numbers ofB-lym-
phocytes sometimes forming follicles but also invading and destroying intestinal glandu-
lar epithelium to produce the so-called lymphoepithelial lesions. These B-cells are not
always obvious in routinely stained sections but areclearly seen in preparations immunos-
tained with antibodies specific for B-cells. The invasive nature ofthis B-cell infiltrate was
regarded as evidence for the neoplastic nature of IPSID de novo. This circumstantial evi-
dence that IPSID is a neoplasm de novo was soon further substantiated by identifying
immunoglobulin light chain restriction in a small number ofotherwise characteristic cases
[13] and, later, by showing monoclonal immunoglobulin gene rearrangement by Southern
blotting in 3 cases of IPSID, 2 of which were at stage A [14].
MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA
In 1983 Isaacson and Wright [15] described a case ofprimary low grade B-cell gas-
tric lymphoma highlighting the similarity of the histological features to a case of IPSID
described in parallel. They proposed that both lesions demonstrated the features of
mucosa associated lymphoid tissue (MALT) (Figure 1) and coined the term MALT lym-
phoma. Subsequently, a number of other extranodal low grade B-cell lymphomas arising
in mucosae were found to exhibit similar features and the MALT concept was expanded
to include a wider variety of extranodal lymphomas [16]. Amongst the MALT lym-
phomas, IPSID is unique in that the neoplastic cells synthesize an abnormal alpha heavy
chain without light chain [17].
The structure of low grade MALT lymphomas closely recapitulates that of Peyer's
patches [18. 19]. Reactive B-cell follicles are a constant feature and these are surrounded
by an infiltrate of cells which are cytologically and immunophenotypically similar to B-
cells ofthe marginal zone which is a prominent feature ofPeyer's patches [20]. The char-
acteristic lymphoepithelial lesions are the neoplastic counterpart of the normal Peyer's
patch dome lymphoepithelium. Low grade MALT lymphomas, including both gastric
lymphoma and IPSID, commonly involve the local draining lymph nodes but peripheral
spread, if it occurs, is a late event; this results in a very favorable prognosis quite unlike
that of the indolent yet inexorably progressive and widely disseminated low grade B-cell
lymphomas of lymph nodes [21]. This pattern of clinical behavior is well illustrated by
both low grade gastric lymphoma and IPSID although in the latter this is somewhat coun-
tered by the effects of the accompanying malabsorption which is often severe and may on
its own prove fatal relatively early in the course of the disease.
The tendency for low grade MALT lymphomas to remain localized to their site ofori-
gin forprolonged periods is well illustrated by both gastric lymphoma and IPSID. In seek-
ing an explanation for this tendency, a number offactors need to be considered. The pos-
sibility that this group oflesions are, after all, not malignant lymphomas but, as has been
previously suggested, hyperplasias or at best "pseudolymphomas" needs to be critically
addressed. The possibility that lymphocyte-homing phenomena, which have been shown
to operate in mucosal immunity, might underlie the curious behavior of MALT lym-
phomas should also be examined and, finally, consideration should be given to the possi-
bility that, although lymphomatous, their behavior might be affected by the presence of a
local antigen.
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Figure 1.
Upper Left: Peyer's patch showing a B cell
follicle (F) with surrounding marginal zone
(M) and lymphoepithelium (arrow).
Lower Left: Low grade gastric MALT lym-
phoma showing reactive B cell follicle (F)
with tumor infiltrate in marginal zone (M)
forming lymphoepithelial lesions (arrows).
Upper Right: Immunoproliferative small
intestinal disease showing reactive B cell
follicle (F) with tumor infiltrate in marginal
zone (M) and lymphoepithelial lesions
(arrows).
Note structural similarity between all three.
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PATHOGENESIS OF IPSID AND MALT LYMPHOMA
The constellation of properties which define a lesion as a malignant tumor include
monoclonality, the presence of a clonal genetic abnormality, invasiveness and the ability
to disseminate. Both low grade gastric MALT lymphoma and IPSID are monoclonal.
Various clonal cytogenetic abnormalities have been identified in both disorders. In gastric
lymphoma trisomy 3 is the most common abnormality being present in 60percent ofcases
but translocations involving chromosome 14q32 at the putative immunoglobulin heavy
chain gene locus have also been reported [22, 23]. Relatively few cytogenetic studies have
been carried out in cases ofIPSID but here too, among other abnormalities, translocations
involving chromosome 14q32 have been reported, importantly, in early cases which were
not thought to be "overtly" lymphomatous [24]. Both low grade gastric lymphoma and
IPSID are invasive but this property in the context of a lymphoproliferative lesion is not
necessarily indicative of malignancy. Dissemination to local lymph nodes is common in
both gastric lymphoma and IPSID but more peripheral dissemination is uncommon in
both conditions, especially the latter. Taking all these factors into consideration the weight
ofthe evidence is that it is, indeed, appropriate to designate both low grade gastric MALT
lymphoma and IPSID as malignant lymphomas.
Lymphocyte homing refers to a receptor ligand system whereby circulating lympho-
cytes express homing receptors which recognize organ or tissue specific vascular address-
ing on high endothelial venules and through this mechanism migrate into specific organs
or tissues. Lymphocyte homing phenomena were first described in the context of MALT
[25] and initially were suggested a possible explanation for the favorable behavior of
MALT lymphomas. There is some evidence for this in that MALT lymphomas, when they
do spread, tend to involve other mucosae, but there is no receptor ligand system suffi-
ciently finely tuned as to cause a lymphoma to home back to itself. Thus although lym-
phocyte homing may influence the behavior of low grade MALT lymphomas it does not,
on its own, provide an explanation for the clinical behavior of these lymphomas.
There is a considerable body of evidence that suggests that the growth of low grade
MALT lymphomas, more specifically gastric lymphoma and IPSID, is under some sort of
immunological control and may be influenced by local antigen. If this were the case it
could explain the tendency of the lymphomas to remain localized since lymphoma cells
disseminating to peripheral locations would fail to proliferate in the absence of the spe-
cific antigen. Many of the histological features of low grade MALT lymphomas [19] are
consistent with this hypothesis. Both low grade gastric lymphoma and IPSID contain vari-
able numbers oftransformed tumor cells and show plasma cell differentiation which tend
to be maximal beneath the surface epithelium. These characteristics would be consistent
with a lumenal or epithelial antigen causing these effects. The phenomenon of "follicular
colonization," [11, 26] whereby lymphoma cell migrate into the centers ofreactive B-cell
follicles, is also seen in both disorders and this, too, is very likely a manifestation of an
antigen effect.
In keeping with the likelihood that the growth oflow grade MALT lymphoma is influ-
enced by antigen are the numerous reports ofsignificant, sometimes complete, regression
ofthe lymphoplasmacytic infiltrate in cases ofIPSID treated with broad spectrum antibi-
otics alone. The effect of the antibiotics is, presumably, to sterilize the small intestinal
lumen which removes the (bacterial) antigen(s) responsible fordriving the proliferation of
the lymphoma cells. The evaluation ofthe effects oftreating IPSID with antibiotics alone
is fraught with difficulty because of insufficient information regarding the diagnostic cri-
teria, the frequent use of other forms of therapy and the large proportion of cases lost to
follow up. However, analysis of two recent papers including one from Cape Town [27,
28], has shown convincing long-standing remissions in at least 5 of 13 stage A IPSID
patients treated with antibiotics alone.
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The link between Helicobacterpylori infection and gastric MALT lymphoma is sim-
ilar to that between the putative small intestinal infection and IPSID only much more fully
characterized. In the normal stomach there is no MALT which begs the question as to the
origin of gastric lymphoma. As a consequence of infection with H. pylori, MALT, com-
prising lymphoid follicles and a lymphoepithelium, accumulates in the gastric mucosa.
Several groups have shown that this acquisition of MALT by the stomach is highly spe-
cific for H. pylori infection [29-31]. Following up on these observations, Wotherspoon et
al. examined 110 cases of gastric lymphoma for the presence of H. pylori and were able
to identify the organism in 101 (92 percent) of these [32]. Further evidence for a link
between this infection and gastric lymphoma came from an epidemiological study which
showed a high incidence of gastric lymphoma in northeastern Italy [33], where there is a
high prevalence ofH. pylori infection and a case control study which showed that patients
with gastric lymphoma are much more likely to have been infected with H. pylori than
those with other types of lymphoma.
In the context of this circumstantial evidence, Hussell et al [35] investigated the in
vitro responses ofcells teased from gastric lymphomas when co-cultured with heat-killed
H. pylori. Hussell et al. were able to show that cells from individual cases of low grade
gastric MALT lymphoma were stimulated to divide and secrete tumor specific
immunoglobulin by specific strains of H. pylori. These and subsequent experiments [36]
showed that this reaction on the part ofthe lymphomatous B-cells was mediated via con-
tact with H. pylori specific T-cells and that the B-cells themselves did not produce H.
pylori specific immunoglobulin [371.
In a parallel clinical study, Wotherspoon et al. [38] treated 6 patients with low grade
gastric MALT lymphoma, all of whom were infected with H. pylori, with antibiotics to
eradicate the organism. This therapy resulted in complete regression of the lymphoma in
5 cases. These clinical responses have been confirmed in at least two subsequent studies
[39, 40]. Most ofthe successfully treated cases have been early superficial lesions and fur-
ther work is needed to study the effects of antibiotic therapy on more deeply invasive
tumors. Another interesting aspect will be to investigate whether there are any specific
genetic changes in those gastric lymphomas that have disseminated beyond the stomach
and local lymph nodes whose growth, presumably, would be independent of H. pylori
stimulated T-cells.
The discovery that the growth ofgastric MALT lymphomas is under antigen specific
T-cell control has direct bearing on the nature ofthe clinical response of IPSID to antibi-
otics. Given that the B-cells in IPSID synthesize an incomplete immunoglobulin molecule
which specifically lacks the variable region and, therefore, would not express any antigen
receptors, it was unclear how the growth ofthis tumor could be influenced by removal of
antigen(s). As in gastric lymphoma these B-cells would, however, still be open to stimu-
lation by antigen specific T-cells via the CD40/CD40 ligand system [36].
The early suggestions that low grade primary gastric lymphoma and IPSID exempli-
fied a distinctive new type of lymphoma have been substantiated by further studies.
Clinical experience with IPSID hinted, for the first time, that bacterial infection might
play an important role in the pathogenesis of lymphoma and this has been borne out by
studies firmly linking H. pylori to the development and progression ofgastric MALT lym-
phoma. These studies have also drawn attention to the role oftumor-infiltrating T-cells in
supporting the growth of low grade MALT lymphomas. Future work will develop these
themes further in identifying the nature of the antigens operative in IPSID and other
MALT lymphomas, and clarifying the mechanisms of T-cell help for the growth of low
grade MALT and, possibly nodal lymphomas.
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